Female artists faced many problems in previous epochs….
tilak
Designing Biosimilar Studies: Global Regulatory Expectations and Practical Considerations
The biosimilar industry is entering a transformative era. As numerous biologic products approach patent expiration over the next decade, pharmaceutical companies are increasingly focused on developing high-quality biosimilars that can meet growing market demand. However, success in biosimilar development depends on more than analytical similarity alone.…
Understanding Rare Diseases, Orphan Drugs, and Canada's Evolving Regulatory Landscape
Rare diseases affect millions of people worldwide, yet each individual condition impacts only a small percentage of the population. Despite their rarity, these diseases collectively represent a significant healthcare challenge, requiring specialized research, innovative treatments, and supportive regulatory frameworks.
As awareness grows and medical science…